Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Romain

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric studyA Chassevent, M L Jourdan, S Romain, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1995
Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissuesS Romain, F Spyratos, C Lainé-Bidron, et al.
British Journal of Cancer|July 17, 1999
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre studyP Broët, F Spyratos, S Romain, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapseM Roux-Dosseto, S Romain, N Dussault, et al.
International Journal of Cancer|August 9, 1995
Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?P Bonnier, C Charpin, C Lejeune, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patientsP Broët, S Romain, A Daver, et al.
International Journal of Cancer|June 30, 1998
Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancerP Bonnier, F Bessenay, A J Sasco, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Inflammatory carcinoma of the breastP Bonnier, L Piana, A Khouzami, et al.
International Journal of Cancer|April 22, 1997
DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?S Romain, P M Martin, J G Klijn, et al.
International Journal of Cancer|August 24, 2000
Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter studyS Romain, F Spyratos, F Descotes, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric studyA Chassevent, M L Jourdan, S Romain, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1995
Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissuesS Romain, F Spyratos, C Lainé-Bidron, et al.
British Journal of Cancer|July 17, 1999
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre studyP Broët, F Spyratos, S Romain, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapseM Roux-Dosseto, S Romain, N Dussault, et al.
International Journal of Cancer|August 9, 1995
Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?P Bonnier, C Charpin, C Lejeune, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patientsP Broët, S Romain, A Daver, et al.
International Journal of Cancer|June 30, 1998
Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancerP Bonnier, F Bessenay, A J Sasco, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Inflammatory carcinoma of the breastP Bonnier, L Piana, A Khouzami, et al.
International Journal of Cancer|April 22, 1997
DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?S Romain, P M Martin, J G Klijn, et al.
International Journal of Cancer|August 24, 2000
Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter studyS Romain, F Spyratos, F Descotes, et al.
Pageof 6